About US
Contact us
-
PHEXCOM Events &Advertisement Cooperation 20222021/8/20
-
Viatris in talks with West Virginia University on plan that could keep idled Morgantown factory afloatWhile Viatris didn't find a buyer in time to save the former Mylan plant it shuttered last month, the company says it's looking to secure "the next best possible future" for the West Virginia facilit2021/8/16
-
J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: reportFive years since the U.S. saw itsfirstmimic of a biologic drug with Sandoz’s Zarxio, new evidence suggests some innovator biologics are starting to feel the heat from their complex copycats. Between2021/8/16
-
With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—againPfizer and Moderna are getting used to readjusting their projected COVID-19 vaccine sales. Now another recalibration may be in order. The FDA is set toauthorizea third dose of their COVID-19 shots fo2021/8/13
-
Evotec's new Washington site is ready to roll, and the U.S. has already called first dibs for COVID-19 antibody suppliesWith its inaugural commercial plant, Evotec says it’s ready to drum up customers at every link of the biologics chain. Its first order of business? Making investigational COVID-19 antibody drugs for2021/8/13
-
AstraZeneca, Daiichi Sankyo build Enhertu's blockbuster case with breast cancer win against Roche's KadcylaAstraZeneca and Daiichi Sankyo’s Enhertu is shouldering big expectations. With a new head-to-head trial win against Roche’s Kadcyla, the companies are showing their antibody-drug conjugate could inde2021/8/10
-
Roche snags coveted Polivy win in newly diagnosed lymphoma. But is it enough to change 2 decades of established treatment practices?After two years of meager sales for Polivy, Roche is trumpeting a much-coveted clinical win that could open up a blockbuster market for the drug. Still, questions remain about the exact size of the o2021/8/10
-
FDA expands EUA for Lilly-Incyte’s baricitinib as Covid-19 monotherapyThe US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Eli Lilly and Incyte’s drug, baricitinib, for Covid-19 treatment with or without remdesivir. Discovere2021/8/4
-
Takeda and Frazier to launch HilleVax for norovirus vaccine developmentTakeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214 (previous2021/8/4
-
Astellas and Minovia enter deal for mitochondrial cell therapiesMinovia Therapeutics and Astellas Pharma have signed a global strategic partnership and licence agreement to research, develop and market new cell therapy programmes for mitochondrial dysfunction-dri2021/8/2